BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6421245)

  • 1. [Serum levels of mitomycin C following a high-dose continuous hyperthermic peritoneal perfusion].
    Hamazoe R; Koga S; Maeta M; Shimizu N; Sumi K; Oda M; Karino T; Yamane T; Kanayama H; Osaki Y
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):97-103. PubMed ID: 6421245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Continuous hyperthermic peritoneal perfusion with cisplatin and mitomycin C for peritoneal dissemination in gastric cancer].
    Fujimura T; Yonemura Y; Urade M; Sugiyama K; Hasegawa H; Hashimoto T; Miyata R; Matsuda Y; Katayama K; Yamaguchi A
    Nihon Gan Chiryo Gakkai Shi; 1989 Jul; 24(7):1415-24. PubMed ID: 2509604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of gastric cancer patients with peritoneal metastasis by continuous hyperthermic peritoneal infusion with mitomycin C and cisplatin].
    Yonemura Y; Fujimura T; Takekawa S; Ohoyama S; Kimura H; Kamata T; Katayama K; Matsuki N; Sawa T; Sakuma H
    Gan To Kagaku Ryoho; 1991 Feb; 18(2):271-6. PubMed ID: 1899549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prophylactic and therapeutic continuous hyperthermic peritoneal perfusion for peritoneal metastases of gastric cancer].
    Koga S
    Gan No Rinsho; 1985 Jul; 31(9 Suppl):1103-5. PubMed ID: 3932711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental studies on continuous hyperthermic peritoneal perfusion in the treatment for peritoneal metastases of cancer].
    Hamazoe R
    Nihon Geka Gakkai Zasshi; 1983 Nov; 84(11):1117-29. PubMed ID: 6425635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Total body hyperthermia and continuous hyperthermic peritoneal perfusion as an adjuvant therapy in advanced gastric cancer].
    Sugiyama Y; Suzuki H; Hada R; Miyagishima K; Yokoyama M; Daidouji K; Murata A; Yamazaki S; Mikami Y; Ozawa M
    Gan To Kagaku Ryoho; 1991 Apr; 18(4):619-24. PubMed ID: 1901477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperthermic peritoneal perfusion combined with anticancer chemotherapy as prophylactic treatment of peritoneal recurrence of gastric cancer.
    Kaibara N; Hamazoe R; Iitsuka Y; Maeta M; Koga S
    Hepatogastroenterology; 1989 Apr; 36(2):75-8. PubMed ID: 2499527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of disappearance of peritoneal dissemination in gastric cancer induced by continuous hyperthermic peritoneal perfusion with cisplatin and mitomycin C].
    Fujimura T; Yonemura Y; Urade M; Sugiyama K; Hasegawa H; Hashimoto T; Miyata R; Matsuda Y; Katayama K; Yamaguchi A
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2331-4. PubMed ID: 3136703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic outcomes of continuous hyperthermic peritoneal perfusion against advanced gastric cancer with peritoneal carcinomatosis.
    Kunisaki C; Shimada H; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Takahashi M
    Hepatogastroenterology; 2006; 53(69):473-8. PubMed ID: 16795995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new surgical approach (peritonectomy) for the treatment of peritoneal dissemination.
    Yonemura Y; Fujimura T; Fushida S; Fujita H; Bando E; Nishimura G; Miwa K; Endou Y; Tanaka M; Sasaki T
    Hepatogastroenterology; 1999; 46(25):601-9. PubMed ID: 10228868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of continuous hyperthermic peritoneal perfusion using high-dose cis-diamminedichloroplatinum for peritoneal dissemination of gastric cancers].
    Yonemura Y; Matsuda Y; Miyata R; Hashimoto T; Takashima T; Sawa T; Takegawa S; Miyazaki I
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):134-8. PubMed ID: 4038444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intraoperative chemotherapy with intraperitoneal activated carbon particles adsorbing mitomycin C against peritoneal dissemination of gastric cancer].
    Iwamoto A; Takahashi T; Sasabe T; Itoh M; Kondoh S; Seiki K; Yoneyama C; Shimotsuma M; Hagiwara A; Yamaguchi T
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2748-51. PubMed ID: 2506820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic analysis in intraperitoneal hyperthermic chemotherapy of far-advanced gastric cancer patients.
    Kobayashi K; Fujimoto S; Shrestha RD; Kokubun M; Kikuchi S; Konno C; Ohta M; Takahashi M; Okui K
    Gan No Rinsho; 1989 Aug; 35(9):1016-20. PubMed ID: 2504971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectiveness of continuous hyperthermic peritoneal perfusion for the peritoneal dissemination of gastric cancer].
    Akiyama H; Kunisaki C; Nomura M; Matsuda G; Otsuka Y; Ono H; Shimada H
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2168-73. PubMed ID: 12484029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intraperitoneal chemotherapy in gastric cancer patients with peritoneal dissemination].
    Hirono Y; Katayama K; Murakami M; Iida A; Yamaguchi A
    Gan To Kagaku Ryoho; 2005 Oct; 32(10):1404-9. PubMed ID: 16227738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Continuous hyperthermic peritoneal perfusion (CHPP) therapy in advanced gastric cancer].
    Suzuki H; Miyagishima K; Gasa F; Hakamada K; Seino K; Hada R; Mikami Y; Sugiyama Y; Konn M; Ono K
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):1769-72. PubMed ID: 1908652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous hyperthermic peritoneal perfusion for peritoneal dissemination of gastric cancer.
    Akiyama H; Yamaoka H; Tanaka K; Ishikawa T; Ichikawa Y; Wakasugi J; Nagashima Y; Shimada H
    Hepatogastroenterology; 1998; 45(24):2079-86. PubMed ID: 9951869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous hyperthermic peritoneal perfusion with cisplatin for the treatment of peritoneal mesothelioma.
    Ma GY; Bartlett DL; Reed E; Figg WD; Lush RM; Lee KB; Libutti SK; Alexander HR
    Cancer J Sci Am; 1997; 3(3):174-9. PubMed ID: 9161783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study.
    Yonemura Y; de Aretxabala X; Fujimura T; Fushida S; Katayama K; Bandou E; Sugiyama K; Kawamura T; Kinoshita K; Endou Y; Sasaki T
    Hepatogastroenterology; 2001; 48(42):1776-82. PubMed ID: 11813623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective delivery of high levels of mitomycin C to peritoneal carcinomatosis using a new dosage form.
    Hagiwara A; Takahashi T; Lee R; Ueda T; Takeda M; Itoh T
    Anticancer Res; 1986; 6(5):1161-4. PubMed ID: 3099630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.